within Pharmacolibrary.Drugs.C_CardiovascularSystem.C07F_BetaBlockingAgentsOtherCombinations.C07FX04_BisoprololAndAcetylsalicylicAcid;
model BisoprololAndAcetylsalicylicAcid 
   extends Pharmacolibrary.Drugs.ATC.C.C07FX04;

  annotation(Documentation(
    info ="<html><body><p>Bisoprolol is a cardioselective beta-1 adrenergic receptor blocker used primarily for treating hypertension, angina, and chronic heart failure. Acetylsalicylic acid (aspirin) is a nonsteroidal anti-inflammatory drug with antiplatelet activity, used for pain, fever, inflammation, and prevention of cardiovascular events such as heart attack and stroke. The combination is intended for patients with cardiovascular disease to provide both beta-blockade and antiplatelet effects. This combination is approved and prescribed today for cardiovascular risk management.</p><h4>Pharmacokinetics</h4><p>There are no published clinical pharmacokinetic studies specifically for the fixed combination product (C07FX04) of bisoprolol and acetylsalicylic acid. The following parameters are estimated based on the pharmacokinetics of bisoprolol and acetylsalicylic acid when administered together orally as separate agents in healthy adults.</p><h4>References</h4><ol><li><p>Marano, M, et al., &amp; Di Nardo, M (2024). Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. <i>Toxicology reports</i> 13 101683â€“None. DOI:<a href=&quot;https://doi.org/10.1016/j.toxrep.2024.101683&quot;>10.1016/j.toxrep.2024.101683</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39027424/&quot;>https://pubmed.ncbi.nlm.nih.gov/39027424</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end BisoprololAndAcetylsalicylicAcid;
